406 filings
Page 6 of 21
425
6znjkodwb
15 Nov 22
Business combination disclosure
4:03pm
8-K
cjfsvcz41lcgj
15 Nov 22
Kineta Announces FDA Acceptance of Investigational New Drug (IND) Application for KVA12123 for the Treatment of Advanced Solid Tumors
4:02pm
425
zgd48bys6y4
14 Nov 22
Business combination disclosure
8:50am
8-K
sgrusilv ui
14 Nov 22
Yumanity Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Developments
8:37am
EFFECT
9w5mn71gk6afiwp6tq
14 Nov 22
Notice of effectiveness
12:15am
424B3
canm4v34z2y8 uyuux3
10 Nov 22
Prospectus supplement
4:21pm
CORRESP
svoarv mxhw06r8p6aws
8 Nov 22
Correspondence with SEC
12:00am
CORRESP
dysm7blmv 0oivwqzmjp
4 Nov 22
Correspondence with SEC
12:00am
UPLOAD
gw92vg8
1 Nov 22
Letter from SEC
12:00am
425
huzayo
27 Oct 22
Business combination disclosure
7:15am
8-K
cd0jdmauabkw9jbyx
27 Oct 22
Kineta to Present Pre-clinical Data on VISTA and CD27 Programs at SITC 2022 Annual Meeting
7:13am
425
5gscbyd39ciflsffko20
26 Oct 22
Business combination disclosure
5:17pm
8-K
p9k6h rscqi2la247zn
26 Oct 22
Regulation FD Disclosure
5:14pm
425
5z59nd0kmzrajp 1aknz
26 Oct 22
Business combination disclosure
5:10pm
8-K
5hanl8y0ud
26 Oct 22
Regulation FD Disclosure
5:08pm
425
6yvqpr7p 6x6dgn
24 Oct 22
Business combination disclosure
8:00am
8-K
ruq2 2c26
24 Oct 22
Entry into a Material Definitive Agreement
7:59am